Hemispherx Biopharma Inc. | Mutual Funds
Mutual Funds that own Hemispherx Biopharma Inc.
Vanguard Extended Market Index Fund
361,415
0.77%
0
0%
07/31/2018
Vanguard Total Stock Market Index Fund
101,255
0.21%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
63,934
0.14%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
13,768
0.03%
0
0%
09/06/2018
12,113
0.03%
0
0.01%
09/05/2018
Fidelity Spartan Total Market Index Fund
10,898
0.02%
0
0%
07/31/2018
BlackRock Master Extended Market Index Series
5,727
0.01%
0
0%
01/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
2,709
0.01%
0
0%
06/30/2018
Vanguard Balanced Index Fund
1,300
0%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
895
0%
0
0%
07/31/2018
| Address |
2117 South West Highway 484
Ocala Florida 32801
United States
|
|
Employees
|
- |
| Website |
http://www.hemispherx.net |
| Updated |
09/14/2018 |
| Hemispherx Biopharma, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. |
